###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 811 816 <span type="species:ncbi:9606">human</span>
DNA nonhomologous end-joining (NHEJ) and homologous recombination are two distinct pathways of DNA double-strand break repair in mammalian cells. Biochemical and genetic studies showed that DNA ends can also be joined via microhomology-mediated end joining (MHEJ), especially when proteins responsible for NHEJ, such as Ku, are reduced or absent. While it has been known that Ku-dependent NHEJ requires DNA ligase IV, it is unclear which DNA ligase(s) is required for Ku-independent MHEJ. In this study, we used a cell-free assay to determine the roles of DNA ligases I, III and IV in MHEJ and NHEJ. We found that siRNA mediated down-regulation of DNA ligase I or ligase III in human HTD114 cells led to impaired end joining that was mediated by 2-, 3- or 10-bp microhomology. In addition, nuclear extract from human fibroblasts harboring a mutation in DNA ligase I displayed reduced MHEJ activity. Furthermore, treatment of HTD114 nuclear extracts with an antibody against DNA ligase I or III also significantly reduced MHEJ. These data indicate that DNA ligases I and III are required in MHEJ. DNA ligase IV, on the contrary, is not required in MHEJ but facilitates Ku-dependent NHEJ. Therefore, MHEJ and NHEJ require different DNA ligases.
###end p 2
###begin p 3
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 517 519 517 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CS</sub>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4 B5 B6 B7 B8 B9 B10 B11 B12 B13">4&#8211;13</xref>
###xml 1144 1148 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1199 1203 1199 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aprt</italic>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1165 1170 <span type="species:ncbi:9606">human</span>
###xml 1329 1334 <span type="species:ncbi:10090">mouse</span>
DNA double-strand breaks (DSBs) are the most serious form of DNA damage and a single unrepaired DSB can lead to cell death (1). In mammalian cells, there are at least two enzymatically distinct pathways for the repair of DSBs, homologous recombination (HR) and nonhomologous end joining (NHEJ). HR uses a homologous template (most frequently the sister chromatid) to carry out DSB repair, whereas NHEJ joins two ends without the requirement for extensive homology. Proteins known to be involved in NHEJ include DNA-PKCS (the catalytic subunit of DNA-dependent protein kinase), Ku70/Ku80 heterodimer, XRCC4 (X-ray Cross Complementing factor 4), and DNA ligase IV (2,3). However, DNA ends can also be joined via microhomologous sequences flanking the break point, especially when proteins responsible for NHEJ, such as Ku, are absent or limiting in mammalian cells (4-13). Microhomology-mediated end joining (MHEJ) is always accompanied by a deletion that spans one of the two homologous sequences and the intervening sequence, if any, and thus is a mutagenic repair pathway. Indeed, microhomologies were observed at deletion break points in the HPRT gene in primary human fibroblasts (14) and in the Aprt gene in hamster cells (15). Furthermore, translocations mediated by MHEJ were frequently detected in pre-B cell lymphomas in mouse models (16).
###end p 3
###begin p 4
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1284 1286 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1464 1466 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1574 1576 1574 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1759 1761 1752 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1920 1922 1909 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 2031 2033 2020 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 2105 2107 2094 2096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 2158 2160 2147 2149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2205 2207 2194 2196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CS</sub>
###xml 2259 2261 2248 2250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Little is known about the factors involved in MHEJ, but it can be assumed that the MHEJ pathway may consist of a series of steps, culminating in the sealing of DNA nicks by the action of a DNA ligase. DNA ligases catalyze the joining of nicked DNA in DNA replication, recombination and repair (17). Eukaryotic cells encode three well-characterized ATP-dependent DNA ligases, DNA ligases I, III and IV, each specializing in distinct pathways of DNA repair and replication (18). Although these DNA ligases vary in sequence and size, sequence and structural analyses have shown that they contain a common catalytic core (18). While the central core of the enzyme carries out the catalytic function of sealing nicked DNA, other domains may determine the specificity of the various ligases in different DNA metabolic reactions, e.g. by targeting ligases to different parts of the nucleus or by mediating interactions with different proteins. DNA ligase I is involved in at least two distinct processes within the nucleus: the joining of Okazaki fragments during DNA replication, and the ligation of a newly synthesized patch during base excision repair (BER) (17). DNA ligase I is recruited to sites of DNA replication by its interaction with proliferating cell nuclear antigen (PCNA) (19,20). It has been shown that the loss of its PCNA binding activity severely compromised the ability of DNA ligase I to join Okazaki fragments, and to participate in long-patch BER (21). Two isoforms of DNA ligase III resulting from alternately spliced mRNA variants have been characterized (22). Ligase IIIalpha is ubiquitously distributed, whereas ligase IIIbeta has been detected only in testes, where it is believed to play a role in recombination during meiotic prophase (22). DNA ligase IIIalpha interacts with XRCC1 (X-ray Cross Complementing factor 1) via its carboxy-terminal BRCT (BRCA C-terminal) domains and functions in BER (23). DNA ligase IV is distinct from other DNA ligases in that it possesses two tandem C-terminal BRCT domains (18). This protein forms a complex with XRCC4, which appears to stabilize (24) and stimulate the overall activity of ligase IV (25). This complex further interacts with DNA-PKCS and the Ku70/Ku80 heterodimer to function in NHEJ (26).
###end p 4
###begin p 5
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Though many studies have revealed the role of DNA ligases in DNA repair pathways, such as NHEJ and BER, a systematic study of these ligases in the MHEJ pathway has been lacking. We recently developed a cell-free assay, with which factors modulating two end-joining pathways, i.e. Ku-dependent NHEJ and MHEJ, can be evaluated (9). We previously showed that Ku and histone H1 facilitate error-free NHEJ and inhibit MHEJ, and that FEN-1 is involved in MHEJ. In the present study, we have determined the roles of DNA ligases I, III and IV in these end-joining pathways. We found that while DNA ligase IV is required to join DNA ends in the Ku-dependent NHEJ pathway, DNA ligase I and ligase III are required in MHEJ.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Cells and cell culture
###end title 7
###begin p 8
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 62 68 <span type="species:ncbi:9913">bovine</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 260 265 <span type="species:ncbi:9606">Human</span>
###xml 481 486 <span type="species:ncbi:9606">human</span>
Human cell line HTD114 was grown in DMEM containing 10% fetal bovine serum (FBS). The DNA ligase I-deficient human primary fibroblast cell line, GM16096, and the DNA ligase IV-deficient human primary fibroblast cell line, GM16088, were obtained from the NIGMS Human Genetic Mutant Cell Repository (Camden, NJ, USA), and were grown in Eagle's MEM with Earle's salts supplemented with 1x concentration of MEM nonessential amino acids, 2 mM glutamine and 10% FBS. WI38 normal diploid human fibroblasts were purchased from the American Type Culture Collection (Manassas, VA, USA) and grown in DMEM containing 10% FBS.
###end p 8
###begin title 9
RNA interference
###end title 9
###begin p 10
Twenty-one nucleotide RNA duplexes (most of them have a 3'-deoxy thymidine overhang) were purchased from Ambion, Inc. (Austin, TX, USA). The RNA sequences were as follows: DNA ligase I, siRNA121249, sense, 5'-GGC AUG AUC CUG AAG CAG Att-3', antisense, 5'-UCU GCU UCA GGA UCA UGC Ctt-3'; DNA ligase III, siRNA121668, sense, 5'-CCA CAA AAA AAA UCG AGG Att-3', antisense, 5'-UCC UCG AUU UUU UUU GUG Gtg-3'; siRNA121372, sense, 5'-CGA CCU UUU AGA CUC AAU Utt-3', antisense, 5'-AAU UGA GUC UAA AAG GUC Gtt-3'. A nonsilencing siRNA duplex (sense, 5'-UUC UCC GAA CGU GUC ACG Utt-3', antisense, 5'-ACG UGA CAC GUU CGG AGA Att-3') (Qiagen, Valancia, CA, USA) was used as a nonsilencing control. Each siRNA (20 nM) was transfected into HTD114 cells with siPORT Amine reagent (Ambion, Inc.). Forty-eight hours after transfection, total RNA and nuclear proteins were extracted.
###end p 10
###begin title 11
Real-time PCR for quantification of gene expression
###end title 11
###begin p 12
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
Total RNA from cells was purified using RNeasy kits (Qiagen) and reverse transcribed using the Taqman Reverse Transcription Reagent kit (Applied Biosystems, Foster City, CA, USA). The expression of DNA ligase I, III and IV genes was measured with a quantitative real time PCR assay as previously reported (27). Expression levels were calculated as a ratio of the mRNA level for a given gene relative to the mRNA level for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the same cDNA sample. Primer sequences are: Lig1-1F, 5'-GAA TTC TGA CGC CAA CAT GCA-3', Lig1-1R, 5'-CCG TCT CTC TGC TGC TAT TGG A-3'; Lig3-1F, 5'-GAT CAC GTG CCA CCT ACC TTG T-3', Lig3-1R, 5'-GGC ATA GTC CAC ACA GAA CCG T-3'; Lig4-F, 5'-CAC CTT GCG TTT TCC ACG AA-3', Lig4-R, 5'-CAG ATG CCT TCC CCC TAA GTT G-3'. To determine whether or not a certain ligase siRNA treatment could also knock down other nontargeted ligases, we measured the expression levels of all DNA ligases in all collected RNA samples. For each RNA sample, the real-time PCR was performed in triplicate.
###end p 12
###begin title 13
Nuclear extract preparation
###end title 13
###begin p 14
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
Cells were harvested and washed with ice-cold phosphate buffered saline (PBS). Nuclear protein extracts were prepared as described (9,28). Protein concentration was determined by the Bradford assay (29).
###end p 14
###begin title 15
Immunoblotting
###end title 15
###begin p 16
###xml 589 594 <span type="species:ncbi:10090">mouse</span>
###xml 661 666 <span type="species:ncbi:10090">mouse</span>
###xml 715 719 <span type="species:ncbi:9925">goat</span>
###xml 797 803 <span type="species:ncbi:9986">rabbit</span>
Equivalent amount of nuclear extracts were separated with SDS-PAGE gels and transferred onto polyvinylidene difluoride membranes. Membranes were blocked at room temperature for 30 min in blocking buffer [3% nonfat dry milk in PBS containing 0.1% Tween 20 (T-PBS)] and incubated at 4degreesC overnight with primary antibody diluted in blocking buffer. After five washes with T-PBS, membranes were incubated at room temperature for 1 h with secondary antibody diluted in blocking buffer. Immunoblots were visualized by enhanced chemiluminescence. Primary antibodies used in this study were: mouse anti-DNA ligase I (Novus, Biologicals, Inc., Littleton, CO, USA), mouse anti-DNA ligase III (Novus, Biologicals, Inc.), goat anti-DNA ligase IV (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and rabbit anti-beta-actin (Abcam, Cambridge, MA, USA).
###end p 16
###begin title 17
End-joining substrates
###end title 17
###begin p 18
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 825 833 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1233 1241 1233 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1245 1254 1245 1254 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1293 1294 1293 1294 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1616 1617 1616 1617 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1254 1812 1254 1812 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="19">DNA substrates of end-joining assays. (<bold>A</bold>) The plasmid pUC18PD1/4 was digested with Eco47III and EcoRV, resulting in a blunt-ended linear molecule with a 10-bp direct repeat (ATCCTACAGC) at each end. Deletion of one 10-bp repeat in joined DNA will produce an XcmI restriction site. This particular restriction site can not be created by other joining reactions. (<bold>B</bold>) The plasmids pUC18-2-bp-repeat and pUC18-3-bp-repeat were digested with PshAI, resulting in blunt-ended linear molecules with a 2-bp (AG) or 3-bp (CAG), respectively, direct repeat at each end.</p>
###xml 1254 1812 1254 1812 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="19">DNA substrates of end-joining assays. (<bold>A</bold>) The plasmid pUC18PD1/4 was digested with Eco47III and EcoRV, resulting in a blunt-ended linear molecule with a 10-bp direct repeat (ATCCTACAGC) at each end. Deletion of one 10-bp repeat in joined DNA will produce an XcmI restriction site. This particular restriction site can not be created by other joining reactions. (<bold>B</bold>) The plasmids pUC18-2-bp-repeat and pUC18-3-bp-repeat were digested with PshAI, resulting in blunt-ended linear molecules with a 2-bp (AG) or 3-bp (CAG), respectively, direct repeat at each end.</p></caption>
###xml 1812 1812 1812 1812 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f1"/>
###xml 1245 1812 1245 1812 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="19">DNA substrates of end-joining assays. (<bold>A</bold>) The plasmid pUC18PD1/4 was digested with Eco47III and EcoRV, resulting in a blunt-ended linear molecule with a 10-bp direct repeat (ATCCTACAGC) at each end. Deletion of one 10-bp repeat in joined DNA will produce an XcmI restriction site. This particular restriction site can not be created by other joining reactions. (<bold>B</bold>) The plasmids pUC18-2-bp-repeat and pUC18-3-bp-repeat were digested with PshAI, resulting in blunt-ended linear molecules with a 2-bp (AG) or 3-bp (CAG), respectively, direct repeat at each end.</p></caption><graphic xlink:href="gkn184f1"/></fig>
The construction of linear end-joining substrates with a 10-bp microhomology at both ends (pUC18PD1/4) was described by Liang et al. (9). After cleavage with the restriction enzymes Eco47III and EcoRV, the 2.7-kb linear DNA possesses a 10-bp direct repeat (ATCCTACAGC) at both ends (Figure 1A). Linear end-joining substrates with a 2- or 3-bp microhomology at both ends were also constructed. For the pUC18-2-bp-repeat substrates, a fragment, which was generated by annealing oligonucleotides (2-bp-repeat-F, 5'-AGC TTC GAA TCC GTT CGA CAG AGG TCT-3', and 2-bp-repeat-R, 5'-CTA GAG ACC TCT GTC GAA CGG ATT CGA-3'), was ligated between the HindIII and XbaI sites of pUC18 (Invitrogen, Calsbad, CA, USA). After cleavage with the restriction enzyme PshAI, the 2.7-kb linear DNA possesses a 2-bp direct repeat (AG) at both ends (Figure 1B). For the pUC18-3-bp-repeat substrates, the fragment to be inserted between the HindIII and XbaI sites of pUC18 was generated by annealing oligonucleotides 3-bp repeat-F (5'-AGC TTC GAA TCC GTT CGA CAG CAG TCT-3') and 3-bp repeat-R (5'-CTA GAG ACT GCT GTC GAA CGG ATT CGA-3'). After cleavage with the restriction enzyme PshAI, the 2.7-kb linear DNA carries a 3-bp direct repeat (CAG) at both ends (Figure 1C). Figure 1.DNA substrates of end-joining assays. (A) The plasmid pUC18PD1/4 was digested with Eco47III and EcoRV, resulting in a blunt-ended linear molecule with a 10-bp direct repeat (ATCCTACAGC) at each end. Deletion of one 10-bp repeat in joined DNA will produce an XcmI restriction site. This particular restriction site can not be created by other joining reactions. (B) The plasmids pUC18-2-bp-repeat and pUC18-3-bp-repeat were digested with PshAI, resulting in blunt-ended linear molecules with a 2-bp (AG) or 3-bp (CAG), respectively, direct repeat at each end.
###end p 18
###begin p 19
###xml 39 40 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 362 363 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
DNA substrates of end-joining assays. (A) The plasmid pUC18PD1/4 was digested with Eco47III and EcoRV, resulting in a blunt-ended linear molecule with a 10-bp direct repeat (ATCCTACAGC) at each end. Deletion of one 10-bp repeat in joined DNA will produce an XcmI restriction site. This particular restriction site can not be created by other joining reactions. (B) The plasmids pUC18-2-bp-repeat and pUC18-3-bp-repeat were digested with PshAI, resulting in blunt-ended linear molecules with a 2-bp (AG) or 3-bp (CAG), respectively, direct repeat at each end.
###end p 19
###begin title 20
DNA end-joining assay
###end title 20
###begin p 21
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
The end-joining assay, which evaluates the relative contribution of MHEJ and NHEJ to DNA end joining, using nuclear extracts and DNA substrates containing direct repeats at the ends, was conducted as described (9). Briefly, linearized DNA substrates were incubated with nuclear protein extract at 14degreesC for 2 h. DNA products were deproteinized, purified and separated by electrophoresis through 0.6% agarose gels. The intensity of DNA bands was quantified by using Kodak Gel Logic 100 Imaging System and Kodak 1D Image Analysis Software. The overall end-joining efficiency was calculated as the percentage of end-joined product (dimer and multimers) as a fraction of total DNA in the reaction (monomer, dimer and multimers). All DNA end-joining experiments were repeated at least three times.
###end p 21
###begin p 22
To study the involvement of DNA ligases I and III in MHEJ, we also treated nuclear extract from HTD114 cells (1.6 microg total protein) with dilutions of monoclonal antibody against ligase I or III (Novus Biologicals, Inc.) for 30 min on ice. Nuclear extract was then incubated with 380 ng linear DNA at 14degreesC for 1 h, and DNA end-joined products were analyzed with agarose gel electrophoresis.
###end p 22
###begin title 23
Quantification of MHEJ
###end title 23
###begin p 24
The MHEJ activity of individual protein extract was determined by two steps. First, a quantitative real-time PCR assay was used to measure the total amount of 'head to tail' end-joined products, including MHEJ products. Second, the fraction of end-joined products mediated by microhomology was determined by PCR amplification of the junction of rejoined ends, followed by XcmI digestion for DNA substrates with 10-bp repeats or by DNA sequencing for substrates with 2- and 3-bp repeats. The MHEJ activity of individual nuclear extracts was calculated by multiplying the values obtained in these two steps.
###end p 24
###begin title 25
Step one
###end title 25
###begin p 26
###xml 1329 1330 1329 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1330 1331 1330 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The primers utilized in the quantitative real-time PCR were designed using the Primer Express software (Applied Biosystems). One pair of primers amplifies a DNA fragment containing the rejoined ends. The sequences of the primers for amplifying the 10-bp-mediated products are: forward, 5'-GCC AGT GCC AAG CTA CCA TC -3', and reverse, 5'-TGG AAT TGT GAG CGG ATA ACA AT-3'. The sequences of the primers for amplifying the 2- or 3-bp-mediated end-joined products are: forward, 5'-GTT GTA AAA CGA CGG CCA GTG-3', and reverse, 5'-CAG CTA TGA CAT GAT TAC GAA TTC G-3'. As an internal loading control, a pair of primers were used to amplify a DNA fragment that is about 70 bp away from the junction of rejoined ends. All DNA in the end-joining reaction, including monomers and multimers, can be amplified by this pair of primers, forward, ATT CAG GCT GCG CAA CTG TT-3', and reverse, 5'-CCC AAC TTA ATC GCC TTG CA-3'. An aliquot of the end-joined product was amplified for 40 cycles on a GeneAmp 7900HT Sequence Detection System. Syber Green dye was used for signal detection. All analyses were carried out in triplicate, and nontemplate controls and dissociation curves were used to ensure specific template amplification. For each primer pair, serial dilutions of a control DNA were used to determine a standard curve, and curves with R2 > 0.97 were then used to determine the DNA levels in individual samples.
###end p 26
###begin title 27
Step two
###end title 27
###begin p 28
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
The relative contribution of MHEJ using the 10-bp microhomology was determined by PCR amplification of the junction of rejoined ends, followed by XcmI digestion (9). If joining of the DNA ends is mediated by the 10-bp microhomology, resulting in an XcmI site (CCAN9TGG) at the junction, digestion of PCR products (approximately600 bp) with XcmI would give rise to a 400- and 200-bp fragment. Restriction fragments were separated on a 1% agarose gel. The intensity of the undigested and XcmI-digested fragments was quantified using Kodak Gel Logic 100 Imaging System and Kodak 1D Image Analysis Software. The relative contribution of the 10-bp microhomology-mediated end-joining of the DNA substrate was calculated as the percentage of the XcmI-digested fragments of total PCR products (sum of the undigested and XcmI-digested fragments).
###end p 28
###begin p 29
The relative contribution of MHEJ using the 2- or 3-bp microhomology was determined by sequencing the junction of rejoined ends. After PCR amplification of the junction, the PCR products were purified with the QIAquick PCR purification kit (Qiagen). The purified DNA was cloned into the TOPO TA cloning vector pCR4-TOPO (Invitrogen) according to the manufacturer's recommendations. Individual clones were then sequenced on a Beckman CEQ8000 DNA sequencer.
###end p 29
###begin title 30
RESULTS
###end title 30
###begin p 31
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
We previously established an in vitro assay to evaluate factors involved in MHEJ pathway by using nuclear extracts and linear DNA substrates containing 10-bp repeats at the ends (9). We found that the occurrence of MHEJ in our experimental setting is determined by the relative abundance of nuclear proteins. At low DNA/protein ratios, a Ku-dependent end-joining mechanism predominated over MHEJ. As the DNA/protein ratio increased, end-joining shifted toward MHEJ (9). The present study was conducted to determine the roles of DNA ligases in MHEJ, by using cell extracts that have reduced, defective or inactive DNA ligases.
###end p 31
###begin title 32
Ligase I is required for 10-bp MHEJ
###end title 32
###begin p 33
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 334 343 334 343 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 748 749 748 749 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 869 870 869 870 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 874 875 874 875 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1371 1372 1370 1371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1490 1491 1489 1490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1745 1746 1744 1745 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 2049 2050 2048 2049 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 343 2240 343 2239 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">Down-regulation of DNA ligase I leads to reduced MHEJ activity. HTD114 cells were transfected with siRNA oligonucleotides against DNA ligase I (siRNA 121249). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. RNA samples were reverse transcribed to cDNA, followed by real time-PCR, repeated three times for each RNA sample, to determine the expression level of ligase I (<bold>A</bold>). Data represent the mean and the SEM. Nuclear extracts were analyzed by immunoblotting with the indicated antibodies (<bold>B</bold>). (<bold>C</bold>) End-joining activity affected by the depletion of Lig1. Linearized pUC18PD1/4 DNA (300 ng) was incubated without (lane 1) or with 1 &#956;g nuclear protein extracts from HTD114 transfected with the indicated siRNA oligonucleotides (lanes 2 and 3). The end-joined products were separated by electrophoresis in an agarose gel and the efficiency of end joining was calculated as the percentage of end-joined products (dimer and multimers) in total DNA in the reaction (monomer, dimer and multimers). (<bold>D</bold>) A summary of three independent end-joining experiments performed as in C (above). Data represent the mean and SEM. (<bold>E</bold>) The amount of end-joined products from individual reactions shown in C (above) was determined, in triplicate, with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean and the error bar is SEM. (<bold>F</bold>) End-joined products from reactions shown in C were PCR amplified and subsequently digested with XcmI. The relative contribution of 10-bp MHEJ to DNA end joining was calculated as the percentage of the XcmI-digested fragments in total PCR products (sum of the undigested and XcmI-digested fragments). (<bold>G</bold>) Quantification of MHEJ activity. The MHEJ activity was calculated by multiplying the amount of end-joined products measured from (E) with the relative contribution of MHEJ obtained in (F).</p>
###xml 343 2240 343 2239 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">Down-regulation of DNA ligase I leads to reduced MHEJ activity. HTD114 cells were transfected with siRNA oligonucleotides against DNA ligase I (siRNA 121249). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. RNA samples were reverse transcribed to cDNA, followed by real time-PCR, repeated three times for each RNA sample, to determine the expression level of ligase I (<bold>A</bold>). Data represent the mean and the SEM. Nuclear extracts were analyzed by immunoblotting with the indicated antibodies (<bold>B</bold>). (<bold>C</bold>) End-joining activity affected by the depletion of Lig1. Linearized pUC18PD1/4 DNA (300 ng) was incubated without (lane 1) or with 1 &#956;g nuclear protein extracts from HTD114 transfected with the indicated siRNA oligonucleotides (lanes 2 and 3). The end-joined products were separated by electrophoresis in an agarose gel and the efficiency of end joining was calculated as the percentage of end-joined products (dimer and multimers) in total DNA in the reaction (monomer, dimer and multimers). (<bold>D</bold>) A summary of three independent end-joining experiments performed as in C (above). Data represent the mean and SEM. (<bold>E</bold>) The amount of end-joined products from individual reactions shown in C (above) was determined, in triplicate, with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean and the error bar is SEM. (<bold>F</bold>) End-joined products from reactions shown in C were PCR amplified and subsequently digested with XcmI. The relative contribution of 10-bp MHEJ to DNA end joining was calculated as the percentage of the XcmI-digested fragments in total PCR products (sum of the undigested and XcmI-digested fragments). (<bold>G</bold>) Quantification of MHEJ activity. The MHEJ activity was calculated by multiplying the amount of end-joined products measured from (E) with the relative contribution of MHEJ obtained in (F).</p></caption>
###xml 2240 2240 2239 2239 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f2"/>
###xml 334 2240 334 2239 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="34">Down-regulation of DNA ligase I leads to reduced MHEJ activity. HTD114 cells were transfected with siRNA oligonucleotides against DNA ligase I (siRNA 121249). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. RNA samples were reverse transcribed to cDNA, followed by real time-PCR, repeated three times for each RNA sample, to determine the expression level of ligase I (<bold>A</bold>). Data represent the mean and the SEM. Nuclear extracts were analyzed by immunoblotting with the indicated antibodies (<bold>B</bold>). (<bold>C</bold>) End-joining activity affected by the depletion of Lig1. Linearized pUC18PD1/4 DNA (300 ng) was incubated without (lane 1) or with 1 &#956;g nuclear protein extracts from HTD114 transfected with the indicated siRNA oligonucleotides (lanes 2 and 3). The end-joined products were separated by electrophoresis in an agarose gel and the efficiency of end joining was calculated as the percentage of end-joined products (dimer and multimers) in total DNA in the reaction (monomer, dimer and multimers). (<bold>D</bold>) A summary of three independent end-joining experiments performed as in C (above). Data represent the mean and SEM. (<bold>E</bold>) The amount of end-joined products from individual reactions shown in C (above) was determined, in triplicate, with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean and the error bar is SEM. (<bold>F</bold>) End-joined products from reactions shown in C were PCR amplified and subsequently digested with XcmI. The relative contribution of 10-bp MHEJ to DNA end joining was calculated as the percentage of the XcmI-digested fragments in total PCR products (sum of the undigested and XcmI-digested fragments). (<bold>G</bold>) Quantification of MHEJ activity. The MHEJ activity was calculated by multiplying the amount of end-joined products measured from (E) with the relative contribution of MHEJ obtained in (F).</p></caption><graphic xlink:href="gkn184f2"/></fig>
Using siRNA 121249, we were able to decrease the mRNA level of ligase I in HTD114 cells by 5-fold, as compared with a nonsilencing control siRNA (Figure 2A). Meanwhile, this siRNA did not change the mRNA level of DNA ligases III or ligase IV (data not shown). siRNA 121249 also resulted in no detectable ligase I protein (Figure 2B). Figure 2.Down-regulation of DNA ligase I leads to reduced MHEJ activity. HTD114 cells were transfected with siRNA oligonucleotides against DNA ligase I (siRNA 121249). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. RNA samples were reverse transcribed to cDNA, followed by real time-PCR, repeated three times for each RNA sample, to determine the expression level of ligase I (A). Data represent the mean and the SEM. Nuclear extracts were analyzed by immunoblotting with the indicated antibodies (B). (C) End-joining activity affected by the depletion of Lig1. Linearized pUC18PD1/4 DNA (300 ng) was incubated without (lane 1) or with 1 mug nuclear protein extracts from HTD114 transfected with the indicated siRNA oligonucleotides (lanes 2 and 3). The end-joined products were separated by electrophoresis in an agarose gel and the efficiency of end joining was calculated as the percentage of end-joined products (dimer and multimers) in total DNA in the reaction (monomer, dimer and multimers). (D) A summary of three independent end-joining experiments performed as in C (above). Data represent the mean and SEM. (E) The amount of end-joined products from individual reactions shown in C (above) was determined, in triplicate, with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean and the error bar is SEM. (F) End-joined products from reactions shown in C were PCR amplified and subsequently digested with XcmI. The relative contribution of 10-bp MHEJ to DNA end joining was calculated as the percentage of the XcmI-digested fragments in total PCR products (sum of the undigested and XcmI-digested fragments). (G) Quantification of MHEJ activity. The MHEJ activity was calculated by multiplying the amount of end-joined products measured from (E) with the relative contribution of MHEJ obtained in (F).
###end p 33
###begin p 34
###xml 405 406 405 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 526 527 526 527 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 531 532 531 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1028 1029 1027 1028 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1147 1148 1146 1147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1402 1403 1401 1402 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1706 1707 1705 1706 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
Down-regulation of DNA ligase I leads to reduced MHEJ activity. HTD114 cells were transfected with siRNA oligonucleotides against DNA ligase I (siRNA 121249). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. RNA samples were reverse transcribed to cDNA, followed by real time-PCR, repeated three times for each RNA sample, to determine the expression level of ligase I (A). Data represent the mean and the SEM. Nuclear extracts were analyzed by immunoblotting with the indicated antibodies (B). (C) End-joining activity affected by the depletion of Lig1. Linearized pUC18PD1/4 DNA (300 ng) was incubated without (lane 1) or with 1 mug nuclear protein extracts from HTD114 transfected with the indicated siRNA oligonucleotides (lanes 2 and 3). The end-joined products were separated by electrophoresis in an agarose gel and the efficiency of end joining was calculated as the percentage of end-joined products (dimer and multimers) in total DNA in the reaction (monomer, dimer and multimers). (D) A summary of three independent end-joining experiments performed as in C (above). Data represent the mean and SEM. (E) The amount of end-joined products from individual reactions shown in C (above) was determined, in triplicate, with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean and the error bar is SEM. (F) End-joined products from reactions shown in C were PCR amplified and subsequently digested with XcmI. The relative contribution of 10-bp MHEJ to DNA end joining was calculated as the percentage of the XcmI-digested fragments in total PCR products (sum of the undigested and XcmI-digested fragments). (G) Quantification of MHEJ activity. The MHEJ activity was calculated by multiplying the amount of end-joined products measured from (E) with the relative contribution of MHEJ obtained in (F).
###end p 34
###begin p 35
###xml 278 286 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 412 420 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
To test whether or not the decrease in DNA ligase I affects MHEJ, we incubated 300 ng linear DNA substrates containing 10-bp repeats at the ends with 1 mug nuclear extracts (high DNA/protein ratio) prepared from HTD114 cells that were transfected with siRNA 121249. As shown in Figure 2C and D, siRNA 121249 significantly decreased the overall end-joining efficiency to 40%-a 2.5-fold reduction, of the control (Figure 2D, end-joined products were the result of the 'head to tail', 'head to head' or 'tail to tail' end joining).
###end p 35
###begin p 36
###xml 297 305 297 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 859 860 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 863 871 863 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 887 895 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1089 1097 1088 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1193 1201 1192 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1296 1304 1295 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
We performed a 2-step assay to quantify how much of the decreased end joining was attributed to MHEJ. Since the 10-bp microhomology only mediates the 'head to tail' end joining, we first measured the total amount of 'head to tail' end-joined products using quantitative real time PCR. As shown in Figure 2E, siRNA 121249 decreased the amount of the 'head to tail' end-joined products to about 53% of the control. To determine the fraction of the 'head to tail' end-joined products contributed by MHEJ using the 10-bp repeat, we PCR amplified the ligated DNA products, using primers flanking the end-joined junction, and subsequently digested the PCR products with XcmI. Rejoining of DNA substrates catalyzed by MHEJ using the 10-bp repeat generates an XcmI restriction enzyme site at the joint. No other joining reaction could create such a restriction site (9) (Figure 1A). As shown in Figure 2F, at the 300 ng DNA/1 mug protein ratio, the relative intensity of cleaved PCR fragments by XcmI digestion is 98% in both end-joining reactions. By multiplying the values obtained from step 1 (Figure 2E) with the relative contribution of MHEJ in the corresponding end-joining reaction as shown in Figure 2F, we were able to compare the relative MHEJ activity between individual extracts. As shown in Figure 2G, siRNA 121249 decreased the MHEJ activity to 53% of the control.
###end p 36
###begin p 37
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 452 460 452 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 583 591 582 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 779 787 778 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1066 1074 1063 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1146 1154 1143 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1278 1287 1275 1284 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1345 1346 1342 1343 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1575 1576 1572 1573 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1715 1716 1711 1712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1752 1753 1748 1749 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2089 2090 2071 2072 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1287 2152 1284 2134 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">Mutation in the ligase I gene results in decreased MHEJ. (<bold>A</bold>) Western blot analysis with the antibody against DNA ligase I. GM16096 cells are primary human fibroblast cells that carry two different missense mutations in the ligase I gene. WI38 cells are primary normal human fibroblasts. (<bold>B</bold>) End-joining activities. End-joining assays were carried out using 1 &#956;g nuclear extract prepared from GM16096 or WI38 fibroblast cells. (<bold>C</bold>) Quantification of MHEJ activity. (<bold>D</bold>) Inhibition of end-joining by anti-Ligase 1 antibodies. Nuclear extract from HTD114 cells (1.6 &#181;g total protein) was incubated for 30 min on ice with 1 &#181;g antibody against human DNA ligase I, then incubated with 400 ng linear DNA at 14&#176;C. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (<bold>E</bold>) Quantification of MHEJ affected by anti-ligase 1 antibodies.</p>
###xml 1287 2152 1284 2134 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">Mutation in the ligase I gene results in decreased MHEJ. (<bold>A</bold>) Western blot analysis with the antibody against DNA ligase I. GM16096 cells are primary human fibroblast cells that carry two different missense mutations in the ligase I gene. WI38 cells are primary normal human fibroblasts. (<bold>B</bold>) End-joining activities. End-joining assays were carried out using 1 &#956;g nuclear extract prepared from GM16096 or WI38 fibroblast cells. (<bold>C</bold>) Quantification of MHEJ activity. (<bold>D</bold>) Inhibition of end-joining by anti-Ligase 1 antibodies. Nuclear extract from HTD114 cells (1.6 &#181;g total protein) was incubated for 30 min on ice with 1 &#181;g antibody against human DNA ligase I, then incubated with 400 ng linear DNA at 14&#176;C. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (<bold>E</bold>) Quantification of MHEJ affected by anti-ligase 1 antibodies.</p></caption>
###xml 2152 2152 2134 2134 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f3"/>
###xml 1278 2152 1275 2134 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="38">Mutation in the ligase I gene results in decreased MHEJ. (<bold>A</bold>) Western blot analysis with the antibody against DNA ligase I. GM16096 cells are primary human fibroblast cells that carry two different missense mutations in the ligase I gene. WI38 cells are primary normal human fibroblasts. (<bold>B</bold>) End-joining activities. End-joining assays were carried out using 1 &#956;g nuclear extract prepared from GM16096 or WI38 fibroblast cells. (<bold>C</bold>) Quantification of MHEJ activity. (<bold>D</bold>) Inhibition of end-joining by anti-Ligase 1 antibodies. Nuclear extract from HTD114 cells (1.6 &#181;g total protein) was incubated for 30 min on ice with 1 &#181;g antibody against human DNA ligase I, then incubated with 400 ng linear DNA at 14&#176;C. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (<bold>E</bold>) Quantification of MHEJ affected by anti-ligase 1 antibodies.</p></caption><graphic xlink:href="gkn184f3"/></fig>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
###xml 1436 1441 <span type="species:ncbi:9606">human</span>
###xml 1555 1560 <span type="species:ncbi:9606">human</span>
###xml 1934 1939 <span type="species:ncbi:9606">human</span>
GM16096 fibroblast cells, derived from a compound human heterozygote for ligase I, carry two different missense mutations. The paternal allele showed a substitution of lysine for glutamic acid, resulting from G-to-A transition and the maternal allele carried an Arg771-to-Trp mutation, the result of a C-to-T transition (30). Western blot analysis shows that GM16096 has a significantly lower level of ligase I than normal human fibroblast WI38 cells (Figure 3A). We extracted nuclear proteins from GM16096 and WI38 and incubated 1 mug extract with 500 ng DNA substrate. As shown in Figure 3B, GM16096 had a reduced overall end-joining efficiency. MHEJ using the 10-bp repeat, the predominant pathway of end joining, was reduced by 2.5-fold in the extract prepared from GM16096 (Figure 3C), as compared to WI38. Preincubation of 1.6 mug nuclear protein extract prepared from HTD114 cells with 1 mug monoclonal antibody raised against ligase I before initiating the end-joining assay reduced the overall end-joining efficiency by 7-fold, 1% versus 7% in the control (Figure 3D), and the MHEJ activity by about 5-fold, as compared to the control, (Figure 3E). Taken together, these data clearly demonstrate that DNA ligase I is required for the 10-bp repeat-mediated end joining. Figure 3.Mutation in the ligase I gene results in decreased MHEJ. (A) Western blot analysis with the antibody against DNA ligase I. GM16096 cells are primary human fibroblast cells that carry two different missense mutations in the ligase I gene. WI38 cells are primary normal human fibroblasts. (B) End-joining activities. End-joining assays were carried out using 1 mug nuclear extract prepared from GM16096 or WI38 fibroblast cells. (C) Quantification of MHEJ activity. (D) Inhibition of end-joining by anti-Ligase 1 antibodies. Nuclear extract from HTD114 cells (1.6 microg total protein) was incubated for 30 min on ice with 1 microg antibody against human DNA ligase I, then incubated with 400 ng linear DNA at 14degreesC. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (E) Quantification of MHEJ affected by anti-ligase 1 antibodies.
###end p 37
###begin p 38
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 288 289 288 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 428 429 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 465 466 464 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 802 803 787 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
Mutation in the ligase I gene results in decreased MHEJ. (A) Western blot analysis with the antibody against DNA ligase I. GM16096 cells are primary human fibroblast cells that carry two different missense mutations in the ligase I gene. WI38 cells are primary normal human fibroblasts. (B) End-joining activities. End-joining assays were carried out using 1 mug nuclear extract prepared from GM16096 or WI38 fibroblast cells. (C) Quantification of MHEJ activity. (D) Inhibition of end-joining by anti-Ligase 1 antibodies. Nuclear extract from HTD114 cells (1.6 microg total protein) was incubated for 30 min on ice with 1 microg antibody against human DNA ligase I, then incubated with 400 ng linear DNA at 14degreesC. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (E) Quantification of MHEJ affected by anti-ligase 1 antibodies.
###end p 38
###begin title 39
DNA ligase III is also required in 10-bp MHEJ
###end title 39
###begin p 40
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 321 329 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 540 548 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 649 658 648 657 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1039 1040 1038 1039 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1074 1075 1073 1074 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1093 1094 1092 1093 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1341 1342 1339 1340 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1419 1420 1417 1418 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 658 1445 657 1443 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">Down-regulation of DNA ligase III results in decreased MHEJ activity. HTD114 cells were transfected with nontargeted siRNA (control) or siRNA oligonucleotides against ligase III (siRNA 121668). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. Expression of ligase III at mRNA level and protein level was determined by quantitative real time-PCR (<bold>A</bold>) and by immunoblotting analysis (<bold>B</bold>), respectively. (<bold>C</bold>) End-joining activity affected by the reduction of ligase III. Linearized pUC18PD1/4 DNA (300 ng) was incubated with 1 &#956;g nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase III siRNA 121668 (lane 2). (<bold>D</bold>) A summary of three independent end-joining reactions as performed in (C). (<bold>E</bold>) Quantification of MHEJ.</p>
###xml 658 1445 657 1443 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">Down-regulation of DNA ligase III results in decreased MHEJ activity. HTD114 cells were transfected with nontargeted siRNA (control) or siRNA oligonucleotides against ligase III (siRNA 121668). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. Expression of ligase III at mRNA level and protein level was determined by quantitative real time-PCR (<bold>A</bold>) and by immunoblotting analysis (<bold>B</bold>), respectively. (<bold>C</bold>) End-joining activity affected by the reduction of ligase III. Linearized pUC18PD1/4 DNA (300 ng) was incubated with 1 &#956;g nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase III siRNA 121668 (lane 2). (<bold>D</bold>) A summary of three independent end-joining reactions as performed in (C). (<bold>E</bold>) Quantification of MHEJ.</p></caption>
###xml 1445 1445 1443 1443 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f4"/>
###xml 649 1445 648 1443 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="41">Down-regulation of DNA ligase III results in decreased MHEJ activity. HTD114 cells were transfected with nontargeted siRNA (control) or siRNA oligonucleotides against ligase III (siRNA 121668). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. Expression of ligase III at mRNA level and protein level was determined by quantitative real time-PCR (<bold>A</bold>) and by immunoblotting analysis (<bold>B</bold>), respectively. (<bold>C</bold>) End-joining activity affected by the reduction of ligase III. Linearized pUC18PD1/4 DNA (300 ng) was incubated with 1 &#956;g nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase III siRNA 121668 (lane 2). (<bold>D</bold>) A summary of three independent end-joining reactions as performed in (C). (<bold>E</bold>) Quantification of MHEJ.</p></caption><graphic xlink:href="gkn184f4"/></fig>
siRNA 121668, which targets against DNA ligase III, significantly reduced the mRNA level and the protein level of ligase III (Figure 4A and B). At high DNA/protein (300 ng DNA/1 mug protein) ratio, DNA end-joining activity was significantly decreased in the nuclear extract prepared from cells treated with siRNA 121668 (Figure 4C and D), indicating that reduction in ligase III compromises the end-joining activity. Further quantification of the 10-bp repeat-mediated MHEJ revealed that reduction in ligase III resulted in decreased MHEJ (Figure 4E), suggesting that the decrease in overall end-joining efficiency was caused by a decrease in MHEJ. Figure 4.Down-regulation of DNA ligase III results in decreased MHEJ activity. HTD114 cells were transfected with nontargeted siRNA (control) or siRNA oligonucleotides against ligase III (siRNA 121668). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. Expression of ligase III at mRNA level and protein level was determined by quantitative real time-PCR (A) and by immunoblotting analysis (B), respectively. (C) End-joining activity affected by the reduction of ligase III. Linearized pUC18PD1/4 DNA (300 ng) was incubated with 1 mug nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase III siRNA 121668 (lane 2). (D) A summary of three independent end-joining reactions as performed in (C). (E) Quantification of MHEJ.
###end p 40
###begin p 41
###xml 381 382 381 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 416 417 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 435 436 435 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 683 684 682 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 761 762 760 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
Down-regulation of DNA ligase III results in decreased MHEJ activity. HTD114 cells were transfected with nontargeted siRNA (control) or siRNA oligonucleotides against ligase III (siRNA 121668). Forty-eight hours after transfection, total RNA and nuclear extracts were prepared. Expression of ligase III at mRNA level and protein level was determined by quantitative real time-PCR (A) and by immunoblotting analysis (B), respectively. (C) End-joining activity affected by the reduction of ligase III. Linearized pUC18PD1/4 DNA (300 ng) was incubated with 1 mug nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase III siRNA 121668 (lane 2). (D) A summary of three independent end-joining reactions as performed in (C). (E) Quantification of MHEJ.
###end p 41
###begin p 42
###xml 423 431 420 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 741 749 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 973 981 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1063 1072 1057 1066 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1112 1113 1106 1107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1433 1434 1417 1418 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1511 1512 1495 1496 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1072 1537 1066 1521 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">Requirement of DNA ligase III in MHEJ. (<bold>A</bold>) The effect of anti-ligase III antibodies. Nuclear extract from HTD114 cells (1.6 &#181;g total protein) was incubated for 30 min on ice with the antibody against human DNA ligase III, then incubated with 400 ng linear DNA at 14&#176;C. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (<bold>B</bold>) PCR products of end-joined products shown in (A) were digested with XcmI. (<bold>C</bold>) Quantification of MHEJ.</p>
###xml 1072 1537 1066 1521 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">Requirement of DNA ligase III in MHEJ. (<bold>A</bold>) The effect of anti-ligase III antibodies. Nuclear extract from HTD114 cells (1.6 &#181;g total protein) was incubated for 30 min on ice with the antibody against human DNA ligase III, then incubated with 400 ng linear DNA at 14&#176;C. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (<bold>B</bold>) PCR products of end-joined products shown in (A) were digested with XcmI. (<bold>C</bold>) Quantification of MHEJ.</p></caption>
###xml 1537 1537 1521 1521 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f5"/>
###xml 1063 1537 1057 1521 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="43">Requirement of DNA ligase III in MHEJ. (<bold>A</bold>) The effect of anti-ligase III antibodies. Nuclear extract from HTD114 cells (1.6 &#181;g total protein) was incubated for 30 min on ice with the antibody against human DNA ligase III, then incubated with 400 ng linear DNA at 14&#176;C. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (<bold>B</bold>) PCR products of end-joined products shown in (A) were digested with XcmI. (<bold>C</bold>) Quantification of MHEJ.</p></caption><graphic xlink:href="gkn184f5"/></fig>
###xml 470 475 <span type="species:ncbi:10090">mouse</span>
###xml 1276 1281 <span type="species:ncbi:9606">human</span>
To substantiate the above finding, we preincubated 1.6 mug nuclear protein extract prepared from HTD114 cells with a monoclonal antibody raised against ligase III before initiating the end-joining assay. While the addition of 1 mug anti-ligase III antibody had no effect on the end-joining efficiency, addition of 4 mug antibody resulted in a 3.5-fold reduction, 2% versus 7% in the control, in the end-joining efficiency (Figure 5A). Addition of 4 mug antibody against mouse exonuclease 1, on the other hand, did not affect the end-joining efficiency. XcmI digestion of PCR products of joined DNA showed that the addition of 4 mug ligase III antibody reduced the relative activity of MHEJ using the 10-bp repeat, 73% versus 90% in control (Figure 5B). Together with the result of quantitative real-time PCR amplification of end-joined products, these data indicate that application of 4 mug anti-ligase III antibody caused a 5-fold decrease in 10-bp repeat-mediated MHEJ (Figure 5C). Collectively, these data demonstrate that DNA ligase III is required in MHEJ. Figure 5.Requirement of DNA ligase III in MHEJ. (A) The effect of anti-ligase III antibodies. Nuclear extract from HTD114 cells (1.6 microg total protein) was incubated for 30 min on ice with the antibody against human DNA ligase III, then incubated with 400 ng linear DNA at 14degreesC. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (B) PCR products of end-joined products shown in (A) were digested with XcmI. (C) Quantification of MHEJ.
###end p 42
###begin p 43
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 361 362 351 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 439 440 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 204 209 <span type="species:ncbi:9606">human</span>
Requirement of DNA ligase III in MHEJ. (A) The effect of anti-ligase III antibodies. Nuclear extract from HTD114 cells (1.6 microg total protein) was incubated for 30 min on ice with the antibody against human DNA ligase III, then incubated with 400 ng linear DNA at 14degreesC. After 1 h incubation, DNA products were analyzed by agarose gel electrophoresis. (B) PCR products of end-joined products shown in (A) were digested with XcmI. (C) Quantification of MHEJ.
###end p 43
###begin title 44
DNA ligase IV is not required in 10-bp MHEJ but facilitates Ku-dependent NHEJ
###end title 44
###begin p 45
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 362 370 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 376 385 375 384 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 426 427 425 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 583 584 582 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 674 675 673 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 921 922 919 920 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 997 998 995 996 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1025 1026 1023 1024 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 385 1564 384 1561 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">DNA ligase IV is not required for MHEJ. (<bold>A</bold>) siRNA-mediated down-regulation of DNA ligase IV in HTD114 cells. Expression of ligase IV at the mRNA level was determined by quantitative real time-PCR. (<bold>B</bold>) Expression of ligase IV at the protein level, as determined by the western blot assay. (<bold>C</bold>) End-joining activity in nuclear extract with reduced ligase 4. Linearized DNA substrate (300 ng) was incubated with 1 &#956;g nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase IV siRNA 121372 (lane 2). (<bold>D</bold>) A summary of three independent end-joining reactions as performed in C. (<bold>E</bold>) Quantification of MHEJ. (<bold>F</bold>) DNA ligase IV is required for the Ku-dependent NHEJ pathway. End-joining reactions were carried out by incubating 10 ng DNA substrates with 8 &#956;g nuclear extracts prepared from HTD114 cells treated with nontargeted siRNA, or siRNA 121372 against ligase IV. PCR products of end-joined products were digested with XcmI. The uncut band represents the Ku-dependent NHEJ pathway. NHEJ activity was calculated by multiplying the amount of end-joined products measured by real time PCR with the relative contribution of NHEJ obtained from (A).</p>
###xml 385 1564 384 1561 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">DNA ligase IV is not required for MHEJ. (<bold>A</bold>) siRNA-mediated down-regulation of DNA ligase IV in HTD114 cells. Expression of ligase IV at the mRNA level was determined by quantitative real time-PCR. (<bold>B</bold>) Expression of ligase IV at the protein level, as determined by the western blot assay. (<bold>C</bold>) End-joining activity in nuclear extract with reduced ligase 4. Linearized DNA substrate (300 ng) was incubated with 1 &#956;g nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase IV siRNA 121372 (lane 2). (<bold>D</bold>) A summary of three independent end-joining reactions as performed in C. (<bold>E</bold>) Quantification of MHEJ. (<bold>F</bold>) DNA ligase IV is required for the Ku-dependent NHEJ pathway. End-joining reactions were carried out by incubating 10 ng DNA substrates with 8 &#956;g nuclear extracts prepared from HTD114 cells treated with nontargeted siRNA, or siRNA 121372 against ligase IV. PCR products of end-joined products were digested with XcmI. The uncut band represents the Ku-dependent NHEJ pathway. NHEJ activity was calculated by multiplying the amount of end-joined products measured by real time PCR with the relative contribution of NHEJ obtained from (A).</p></caption>
###xml 1564 1564 1561 1561 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f6"/>
###xml 376 1564 375 1561 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="46">DNA ligase IV is not required for MHEJ. (<bold>A</bold>) siRNA-mediated down-regulation of DNA ligase IV in HTD114 cells. Expression of ligase IV at the mRNA level was determined by quantitative real time-PCR. (<bold>B</bold>) Expression of ligase IV at the protein level, as determined by the western blot assay. (<bold>C</bold>) End-joining activity in nuclear extract with reduced ligase 4. Linearized DNA substrate (300 ng) was incubated with 1 &#956;g nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase IV siRNA 121372 (lane 2). (<bold>D</bold>) A summary of three independent end-joining reactions as performed in C. (<bold>E</bold>) Quantification of MHEJ. (<bold>F</bold>) DNA ligase IV is required for the Ku-dependent NHEJ pathway. End-joining reactions were carried out by incubating 10 ng DNA substrates with 8 &#956;g nuclear extracts prepared from HTD114 cells treated with nontargeted siRNA, or siRNA 121372 against ligase IV. PCR products of end-joined products were digested with XcmI. The uncut band represents the Ku-dependent NHEJ pathway. NHEJ activity was calculated by multiplying the amount of end-joined products measured by real time PCR with the relative contribution of NHEJ obtained from (A).</p></caption><graphic xlink:href="gkn184f6"/></fig>
By using siRNA 121372 that targets ligase IV, we were able to reduce the expression of ligase IV at the mRNA level and at the protein level in HTD114 cells (Figure 6A and B). Incubation of 300 ng DNA substrate with 1 mug nuclear extract isolated from siRNA 121372-transfected HTD114 cells showed that knockdown of ligase IV slightly increased the MHEJ activity (Figure 6C-E). Figure 6.DNA ligase IV is not required for MHEJ. (A) siRNA-mediated down-regulation of DNA ligase IV in HTD114 cells. Expression of ligase IV at the mRNA level was determined by quantitative real time-PCR. (B) Expression of ligase IV at the protein level, as determined by the western blot assay. (C) End-joining activity in nuclear extract with reduced ligase 4. Linearized DNA substrate (300 ng) was incubated with 1 mug nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase IV siRNA 121372 (lane 2). (D) A summary of three independent end-joining reactions as performed in C. (E) Quantification of MHEJ. (F) DNA ligase IV is required for the Ku-dependent NHEJ pathway. End-joining reactions were carried out by incubating 10 ng DNA substrates with 8 mug nuclear extracts prepared from HTD114 cells treated with nontargeted siRNA, or siRNA 121372 against ligase IV. PCR products of end-joined products were digested with XcmI. The uncut band represents the Ku-dependent NHEJ pathway. NHEJ activity was calculated by multiplying the amount of end-joined products measured by real time PCR with the relative contribution of NHEJ obtained from (A).
###end p 45
###begin p 46
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 289 290 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 536 537 535 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 612 613 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 640 641 639 640 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
DNA ligase IV is not required for MHEJ. (A) siRNA-mediated down-regulation of DNA ligase IV in HTD114 cells. Expression of ligase IV at the mRNA level was determined by quantitative real time-PCR. (B) Expression of ligase IV at the protein level, as determined by the western blot assay. (C) End-joining activity in nuclear extract with reduced ligase 4. Linearized DNA substrate (300 ng) was incubated with 1 mug nuclear protein extracts from HTD114 transfected with nontargeted siRNA (lane 1) or the ligase IV siRNA 121372 (lane 2). (D) A summary of three independent end-joining reactions as performed in C. (E) Quantification of MHEJ. (F) DNA ligase IV is required for the Ku-dependent NHEJ pathway. End-joining reactions were carried out by incubating 10 ng DNA substrates with 8 mug nuclear extracts prepared from HTD114 cells treated with nontargeted siRNA, or siRNA 121372 against ligase IV. PCR products of end-joined products were digested with XcmI. The uncut band represents the Ku-dependent NHEJ pathway. NHEJ activity was calculated by multiplying the amount of end-joined products measured by real time PCR with the relative contribution of NHEJ obtained from (A).
###end p 46
###begin p 47
###xml 197 205 197 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 591 599 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 768 776 767 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 940 948 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1053 1062 1052 1061 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1119 1120 1118 1119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1186 1187 1185 1186 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1347 1348 1345 1346 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1425 1426 1423 1424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1062 1451 1061 1449 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">Mutation in the ligase IV gene leads to increased MHEJ. (<bold>A</bold>) Western blot analysis with the antibody against DNA ligase IV. (<bold>B</bold>) End-joining activities. Nuclear extract (1 &#956;g) from GM16088 cells, which carry a mutation in ligase IV gene, was incubated with the DNA substrate (500 ng). (<bold>C</bold>) PCR products of end-joined products shown in (A) were digested with XcmI. (<bold>D</bold>) Quantification of MHEJ.</p>
###xml 1062 1451 1061 1449 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">Mutation in the ligase IV gene leads to increased MHEJ. (<bold>A</bold>) Western blot analysis with the antibody against DNA ligase IV. (<bold>B</bold>) End-joining activities. Nuclear extract (1 &#956;g) from GM16088 cells, which carry a mutation in ligase IV gene, was incubated with the DNA substrate (500 ng). (<bold>C</bold>) PCR products of end-joined products shown in (A) were digested with XcmI. (<bold>D</bold>) Quantification of MHEJ.</p></caption>
###xml 1451 1451 1449 1449 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f7"/>
###xml 1053 1451 1052 1449 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="48">Mutation in the ligase IV gene leads to increased MHEJ. (<bold>A</bold>) Western blot analysis with the antibody against DNA ligase IV. (<bold>B</bold>) End-joining activities. Nuclear extract (1 &#956;g) from GM16088 cells, which carry a mutation in ligase IV gene, was incubated with the DNA substrate (500 ng). (<bold>C</bold>) PCR products of end-joined products shown in (A) were digested with XcmI. (<bold>D</bold>) Quantification of MHEJ.</p></caption><graphic xlink:href="gkn184f7"/></fig>
###xml 38 43 <span type="species:ncbi:9606">human</span>
We also isolated nuclear extract from human fibroblast cells, GM16088, which harbor an Arg278 to His substitution in the ligase IV gene product, leading to a decreased level of ligase IV proteins (Figure 7A). The Arg278 residue is located within a highly conserved motif encompassing the active site, and the substitution was shown to significantly impair ligase IV function (31). Interestingly, end-joining assay showed that the nuclear extract (1 mug) from GM16088 cells has a 2-fold greater efficiency than that from WI38 cells to ligate DNA substrates (500 ng), 10 and 5%, respectively (Figure 7B). XcmI digestion of PCR products of joined DNA revealed that the MHEJ pathway mediated by the 10-bp repeat was more dominant in GM16088 than in WI38, 100% versus 91% (Figure 7C). Furthermore, the overall MHEJ activity in the nuclear extract of ligase IV-deficient GM16088 cells was measured to be 1.8-fold greater than that of WI38 cells (Figure 7D). Thus, two lines of evidence implicated DNA ligase IV in the negative regulation of the MHEJ pathway. Figure 7.Mutation in the ligase IV gene leads to increased MHEJ. (A) Western blot analysis with the antibody against DNA ligase IV. (B) End-joining activities. Nuclear extract (1 mug) from GM16088 cells, which carry a mutation in ligase IV gene, was incubated with the DNA substrate (500 ng). (C) PCR products of end-joined products shown in (A) were digested with XcmI. (D) Quantification of MHEJ.
###end p 47
###begin p 48
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 285 286 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 363 364 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Mutation in the ligase IV gene leads to increased MHEJ. (A) Western blot analysis with the antibody against DNA ligase IV. (B) End-joining activities. Nuclear extract (1 mug) from GM16088 cells, which carry a mutation in ligase IV gene, was incubated with the DNA substrate (500 ng). (C) PCR products of end-joined products shown in (A) were digested with XcmI. (D) Quantification of MHEJ.
###end p 48
###begin p 49
###xml 209 217 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
DNA ligase IV is known to play an important role in DNA-PKcs/Ku-dependent NHEJ. Therefore, it is not unexpected that a decrease in ligase IV expression greatly decreased the Ku-dependent end-joining activity (Figure 6F), which was quantified by using our DNA end-joining at a low DNA/protein ratio (9). However, it is worth noting that when the function of ligase IV is compromised, MHEJ activity is increased (Figures 6 and 7). We can conclude that while DNA ligase IV may facilitate Ku-dependent end joining, it is not required in MHEJ.
###end p 49
###begin title 50
Roles of DNA ligases I, III and IV in 2- and 3-bp MHEJ
###end title 50
###begin p 51
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 842 850 841 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1110 1118 1109 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1316 1324 1315 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1334 1343 1333 1342 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 2245 2252 2243 2250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1343 2254 1342 2252 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">The involvement of DNA ligases I, III and IV in 2- and 3-bp MHEJ. End-joining reactions were carried out by incubating 300 ng linearized pUC18-2-bp-repeat (containing a 2-bp, AG repeat at each end, A) or pUC18-3-bp-repeat (containing a 3-bp, CAG repeat at each end, B) with nuclear extracts (1 &#956;g) prepared from HTD114 cells treated with nontargeted siRNA, or siRNA against ligase I (121248), III (121668), or IV (121372). The amount of end-joined products from individual reactions was determined with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean end-joining efficiency of three independent reactions and the error bar is SEM. The activity of MHEJ using 2-bp (C) or 3-bp (D) microhomology was determined by multiplying the end joining efficiency (A and B) with the fraction of end-joined products mediated by 2- or 3-bp microhomology (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
###xml 1343 2254 1342 2252 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="52">The involvement of DNA ligases I, III and IV in 2- and 3-bp MHEJ. End-joining reactions were carried out by incubating 300 ng linearized pUC18-2-bp-repeat (containing a 2-bp, AG repeat at each end, A) or pUC18-3-bp-repeat (containing a 3-bp, CAG repeat at each end, B) with nuclear extracts (1 &#956;g) prepared from HTD114 cells treated with nontargeted siRNA, or siRNA against ligase I (121248), III (121668), or IV (121372). The amount of end-joined products from individual reactions was determined with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean end-joining efficiency of three independent reactions and the error bar is SEM. The activity of MHEJ using 2-bp (C) or 3-bp (D) microhomology was determined by multiplying the end joining efficiency (A and B) with the fraction of end-joined products mediated by 2- or 3-bp microhomology (<xref ref-type="table" rid="T2">Table 2</xref>).</p></caption>
###xml 2254 2254 2252 2252 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184f8"/>
###xml 1334 2254 1333 2252 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="52">The involvement of DNA ligases I, III and IV in 2- and 3-bp MHEJ. End-joining reactions were carried out by incubating 300 ng linearized pUC18-2-bp-repeat (containing a 2-bp, AG repeat at each end, A) or pUC18-3-bp-repeat (containing a 3-bp, CAG repeat at each end, B) with nuclear extracts (1 &#956;g) prepared from HTD114 cells treated with nontargeted siRNA, or siRNA against ligase I (121248), III (121668), or IV (121372). The amount of end-joined products from individual reactions was determined with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean end-joining efficiency of three independent reactions and the error bar is SEM. The activity of MHEJ using 2-bp (C) or 3-bp (D) microhomology was determined by multiplying the end joining efficiency (A and B) with the fraction of end-joined products mediated by 2- or 3-bp microhomology (<xref ref-type="table" rid="T2">Table 2</xref>).</p></caption><graphic xlink:href="gkn184f8"/></fig>
The results presented earlier showed that DNA ligases I and III, but not ligase IV, are required in 10-bp microhomology-mediated end joining. We further investigated their involvement in DNA end joining mediated by shorter repeat sequences, i.e. 2- or 3-bp repeats. We made two plasmid constructs and used PshAI to obtain linearized DNA substrates, which have 2- or 3-bp direct repeats at the ends (Figure 1B and C). At a high DNA/protein ratio (300/1 ng/mug), with nuclear extracts prepared from HTD114 cells, DNA substrates with 2- or 3-bp repeats were not rejoined as efficiently as those with the 10-bp repeats (data not shown). With the nuclear extracts from HTD114 cells in which DNA ligase I were depleted by siRNA 121249, the efficiency of rejoining the substrates with 2- or 3-bp repeats was decreased, as compared with the control (Figure 8A and B). A greater decrease was observed in HTD114 cells treated with siRNA 121668 against ligase III. With the siRNA 121668 treatment, the efficiencies of rejoining the substrates with 2- and 3-bp repeats were about 49 and 37%, respectively, of the control (Figure 8A and B). In contrast, the siRNA treatment against ligase IV (siRNA 121372) had little effect on the efficiencies of rejoining the substrates with 2- and 3-bp repeats, as compared with the control (Figure 8A and B). Figure 8.The involvement of DNA ligases I, III and IV in 2- and 3-bp MHEJ. End-joining reactions were carried out by incubating 300 ng linearized pUC18-2-bp-repeat (containing a 2-bp, AG repeat at each end, A) or pUC18-3-bp-repeat (containing a 3-bp, CAG repeat at each end, B) with nuclear extracts (1 mug) prepared from HTD114 cells treated with nontargeted siRNA, or siRNA against ligase I (121248), III (121668), or IV (121372). The amount of end-joined products from individual reactions was determined with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean end-joining efficiency of three independent reactions and the error bar is SEM. The activity of MHEJ using 2-bp (C) or 3-bp (D) microhomology was determined by multiplying the end joining efficiency (A and B) with the fraction of end-joined products mediated by 2- or 3-bp microhomology (Table 2).
###end p 51
###begin p 52
###xml 902 909 901 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
The involvement of DNA ligases I, III and IV in 2- and 3-bp MHEJ. End-joining reactions were carried out by incubating 300 ng linearized pUC18-2-bp-repeat (containing a 2-bp, AG repeat at each end, A) or pUC18-3-bp-repeat (containing a 3-bp, CAG repeat at each end, B) with nuclear extracts (1 mug) prepared from HTD114 cells treated with nontargeted siRNA, or siRNA against ligase I (121248), III (121668), or IV (121372). The amount of end-joined products from individual reactions was determined with a quantitative real time-PCR assay as described in Materials and methods section. The bar represents the mean end-joining efficiency of three independent reactions and the error bar is SEM. The activity of MHEJ using 2-bp (C) or 3-bp (D) microhomology was determined by multiplying the end joining efficiency (A and B) with the fraction of end-joined products mediated by 2- or 3-bp microhomology (Table 2).
###end p 52
###begin p 53
###xml 61 68 61 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 359 360 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 386 393 386 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 620 627 620 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 630 638 630 638 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 638 684 638 684 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">Sequences of junctions of end-joined products<sup>a</sup></p>
###xml 638 684 638 684 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54">Sequences of junctions of end-joined products<sup>a</sup></p></caption>
###xml 684 684 684 684 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn184i1.jpg"/>
###xml 684 684 684 684 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><inline-graphic xlink:href="gkn184i1.jpg"/></td>
###xml 684 684 684 684 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkn184i1.jpg"/></td></tr>
###xml 684 684 684 684 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkn184i1.jpg"/></td></tr></tbody>
###xml 684 684 684 684 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><tbody align="left"><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkn184i1.jpg"/></td></tr></tbody></table>
###xml 684 685 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 684 762 684 762 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="55"><sup>a</sup>Nuclear extract was prepared from HTD114 cells treated with different siRNAs.</p>
###xml 684 762 684 762 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="55"><sup>a</sup>Nuclear extract was prepared from HTD114 cells treated with different siRNAs.</p></fn>
###xml 762 763 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 908 927 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#9662;</sup>
###xml 762 1023 762 1005 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="56"><sup>b</sup>The deleted sequences are indicated by capital letters and the flanking sequences are in lower case. Direct repeats are underlined. The symbol, &#8216;<sup>&#9662;</sup>&#8217;, denotes the ends of two joined DNA molecules. Italic letters represent the inserted sequence.</p>
###xml 762 1023 762 1005 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="56"><sup>b</sup>The deleted sequences are indicated by capital letters and the flanking sequences are in lower case. Direct repeats are underlined. The symbol, &#8216;<sup>&#9662;</sup>&#8217;, denotes the ends of two joined DNA molecules. Italic letters represent the inserted sequence.</p></fn>
###xml 1023 1024 1005 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 1023 1046 1005 1028 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57"><sup>c</sup>PR, perfect rejoining.</p>
###xml 1023 1046 1005 1028 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57"><sup>c</sup>PR, perfect rejoining.</p></fn>
###xml 684 1046 684 1028 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="55"><sup>a</sup>Nuclear extract was prepared from HTD114 cells treated with different siRNAs.</p></fn><fn><p textid="56"><sup>b</sup>The deleted sequences are indicated by capital letters and the flanking sequences are in lower case. Direct repeats are underlined. The symbol, &#8216;<sup>&#9662;</sup>&#8217;, denotes the ends of two joined DNA molecules. Italic letters represent the inserted sequence.</p></fn><fn><p textid="57"><sup>c</sup>PR, perfect rejoining.</p></fn></table-wrap-foot>
###xml 630 1046 630 1028 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="54">Sequences of junctions of end-joined products<sup>a</sup></p></caption><table frame="hsides" rules="groups"><tbody align="left"><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="gkn184i1.jpg"/></td></tr></tbody></table><table-wrap-foot><fn><p textid="55"><sup>a</sup>Nuclear extract was prepared from HTD114 cells treated with different siRNAs.</p></fn><fn><p textid="56"><sup>b</sup>The deleted sequences are indicated by capital letters and the flanking sequences are in lower case. Direct repeats are underlined. The symbol, &#8216;<sup>&#9662;</sup>&#8217;, denotes the ends of two joined DNA molecules. Italic letters represent the inserted sequence.</p></fn><fn><p textid="57"><sup>c</sup>PR, perfect rejoining.</p></fn></table-wrap-foot></table-wrap>
###xml 1046 1054 1028 1036 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2.</label>
###xml 1054 1156 1036 1138 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">Fractions of end-joined products mediated by 2-bp (AG) or 3-bp (CAG) repeats at the ends of substrates</p>
###xml 1054 1156 1036 1138 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">Fractions of end-joined products mediated by 2-bp (AG) or 3-bp (CAG) repeats at the ends of substrates</p></caption>
###xml 1156 1170 1138 1152 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">DNA substrates</th>
###xml 1170 1186 1152 1168 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">siRNA treatments</th>
###xml 1186 1243 1168 1225 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No. of EJ products used repeats at the ends of substrates</th>
###xml 1243 1277 1225 1259 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No. of total EJ products sequenced</th>
###xml 1277 1287 1259 1269 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Percentage</th>
###xml 1287 1288 1269 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1294 1295 1276 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1294 1295 1276 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF4"><sup>a</sup></xref>
###xml 1287 1295 1269 1277 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th>
###xml 1156 1295 1138 1277 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">DNA substrates</th><th rowspan="1" colspan="1">siRNA treatments</th><th rowspan="1" colspan="1">No. of EJ products used repeats at the ends of substrates</th><th rowspan="1" colspan="1">No. of total EJ products sequenced</th><th rowspan="1" colspan="1">Percentage</th><th rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr>
###xml 1156 1295 1138 1277 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">DNA substrates</th><th rowspan="1" colspan="1">siRNA treatments</th><th rowspan="1" colspan="1">No. of EJ products used repeats at the ends of substrates</th><th rowspan="1" colspan="1">No. of total EJ products sequenced</th><th rowspan="1" colspan="1">Percentage</th><th rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr></thead>
###xml 1295 1311 1277 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pUC18-2bp-repeat</td>
###xml 1311 1311 1293 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1311 1311 1293 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1311 1311 1293 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1311 1311 1293 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1311 1311 1293 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1295 1311 1277 1293 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pUC18-2bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1311 1311 1293 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1311 1338 1293 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Non-silencing control siRNA</td>
###xml 1338 1340 1320 1322 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">12</td>
###xml 1340 1342 1322 1324 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">19</td>
###xml 1342 1344 1324 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">63</td>
###xml 1344 1344 1326 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1311 1344 1293 1326 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1"/></tr>
###xml 1344 1344 1326 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1344 1354 1326 1336 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lig1 siRNA</td>
###xml 1354 1356 1336 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">15</td>
###xml 1356 1358 1338 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">22</td>
###xml 1358 1360 1340 1342 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">68</td>
###xml 1360 1365 1342 1347 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.735</td>
###xml 1344 1365 1326 1347 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">0.735</td></tr>
###xml 1365 1365 1347 1347 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1365 1375 1347 1357 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lig3 siRNA</td>
###xml 1375 1376 1357 1358 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6</td>
###xml 1376 1378 1358 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">23</td>
###xml 1378 1380 1360 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">26</td>
###xml 1380 1385 1362 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.016</td>
###xml 1365 1385 1347 1367 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">0.016</td></tr>
###xml 1385 1385 1367 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1385 1395 1367 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lig4 siRNA</td>
###xml 1395 1397 1377 1379 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">12</td>
###xml 1397 1399 1379 1381 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">16</td>
###xml 1399 1401 1381 1383 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">75</td>
###xml 1401 1406 1383 1388 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.452</td>
###xml 1385 1406 1367 1388 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">0.452</td></tr>
###xml 1406 1406 1388 1388 <hr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 1406 1406 1388 1388 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="6" rowspan="1"><hr/></td>
###xml 1406 1406 1388 1388 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="6" rowspan="1"><hr/></td></tr>
###xml 1406 1422 1388 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pUC18-3bp-repeat</td>
###xml 1422 1422 1404 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1422 1422 1404 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1422 1422 1404 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1422 1422 1404 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1422 1422 1404 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1406 1422 1388 1404 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pUC18-3bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1422 1422 1404 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1422 1449 1404 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Non-silencing control siRNA</td>
###xml 1449 1451 1431 1433 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">13</td>
###xml 1451 1453 1433 1435 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">21</td>
###xml 1453 1455 1435 1437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">62</td>
###xml 1455 1455 1437 1437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1422 1455 1404 1437 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1"/></tr>
###xml 1455 1455 1437 1437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1455 1465 1437 1447 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lig1 siRNA</td>
###xml 1465 1466 1447 1448 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">9</td>
###xml 1466 1468 1448 1450 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">19</td>
###xml 1468 1470 1450 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">47</td>
###xml 1470 1475 1452 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.356</td>
###xml 1455 1475 1437 1457 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.356</td></tr>
###xml 1475 1475 1457 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1475 1485 1457 1467 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lig3 siRNA</td>
###xml 1485 1486 1467 1468 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">7</td>
###xml 1486 1488 1468 1470 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">22</td>
###xml 1488 1490 1470 1472 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">32</td>
###xml 1490 1495 1472 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.048</td>
###xml 1475 1495 1457 1477 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0.048</td></tr>
###xml 1495 1495 1477 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1495 1505 1477 1487 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lig4 siRNA</td>
###xml 1505 1507 1487 1489 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">11</td>
###xml 1507 1509 1489 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">20</td>
###xml 1509 1511 1491 1493 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">55</td>
###xml 1511 1516 1493 1498 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.654</td>
###xml 1495 1516 1477 1498 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">0.654</td></tr>
###xml 1295 1516 1277 1498 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">pUC18-2bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">0.735</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">0.016</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">0.452</td></tr><tr><td colspan="6" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">pUC18-3bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.356</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0.048</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">0.654</td></tr></tbody>
###xml 1156 1516 1138 1498 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">DNA substrates</th><th rowspan="1" colspan="1">siRNA treatments</th><th rowspan="1" colspan="1">No. of EJ products used repeats at the ends of substrates</th><th rowspan="1" colspan="1">No. of total EJ products sequenced</th><th rowspan="1" colspan="1">Percentage</th><th rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">pUC18-2bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">0.735</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">0.016</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">0.452</td></tr><tr><td colspan="6" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">pUC18-3bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.356</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0.048</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">0.654</td></tr></tbody></table>
###xml 1516 1517 1498 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1516 1813 1498 1795 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59"><sup>a</sup>Comparisons of the fraction of end joined products mediated by 2- or 3-bp repeats at the ends of substrates in HTD114 nuclear extracts with siRNA treatments against different ligases to the control siRNA were done with contingency tables. Significant levels were determined with chi-squared test.</p>
###xml 1516 1813 1498 1795 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF4"><p textid="59"><sup>a</sup>Comparisons of the fraction of end joined products mediated by 2- or 3-bp repeats at the ends of substrates in HTD114 nuclear extracts with siRNA treatments against different ligases to the control siRNA were done with contingency tables. Significant levels were determined with chi-squared test.</p></fn>
###xml 1516 1813 1498 1795 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF4"><p textid="59"><sup>a</sup>Comparisons of the fraction of end joined products mediated by 2- or 3-bp repeats at the ends of substrates in HTD114 nuclear extracts with siRNA treatments against different ligases to the control siRNA were done with contingency tables. Significant levels were determined with chi-squared test.</p></fn></table-wrap-foot>
###xml 1046 1813 1028 1795 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2.</label><caption><p textid="58">Fractions of end-joined products mediated by 2-bp (AG) or 3-bp (CAG) repeats at the ends of substrates</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">DNA substrates</th><th rowspan="1" colspan="1">siRNA treatments</th><th rowspan="1" colspan="1">No. of EJ products used repeats at the ends of substrates</th><th rowspan="1" colspan="1">No. of total EJ products sequenced</th><th rowspan="1" colspan="1">Percentage</th><th rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">pUC18-2bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">0.735</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">0.016</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">0.452</td></tr><tr><td colspan="6" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">pUC18-3bp-repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Non-silencing control siRNA</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig1 siRNA</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.356</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig3 siRNA</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0.048</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lig4 siRNA</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">0.654</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p textid="59"><sup>a</sup>Comparisons of the fraction of end joined products mediated by 2- or 3-bp repeats at the ends of substrates in HTD114 nuclear extracts with siRNA treatments against different ligases to the control siRNA were done with contingency tables. Significant levels were determined with chi-squared test.</p></fn></table-wrap-foot></table-wrap>
DNA sequencing results of the end-joined junctions, shown in Table 1, indicated that majority of end-joining events were mediated by 2- or 3-bp repeats in the controls, accounting for 63% (12/19) or 62% (13/21), respectively, of overall end-joining events. Knockdown of ligase I or IV did not significantly change the fraction of such end-joining events (all P > 0.1, chi-squared test, Table 2). However, knockdown of ligase III, by treatment with siRNA 121668, resulted in a remarkable decline in the contribution of 2- and 3-bp MHEJ events, to 26 and 32%, respectively, of the total end-joining events (both P < 0.05, Table 2). Table 1.Sequences of junctions of end-joined productsaaNuclear extract was prepared from HTD114 cells treated with different siRNAs.bThe deleted sequences are indicated by capital letters and the flanking sequences are in lower case. Direct repeats are underlined. The symbol, 'black triangle down', denotes the ends of two joined DNA molecules. Italic letters represent the inserted sequence.cPR, perfect rejoining.Table 2.Fractions of end-joined products mediated by 2-bp (AG) or 3-bp (CAG) repeats at the ends of substratesDNA substratessiRNA treatmentsNo. of EJ products used repeats at the ends of substratesNo. of total EJ products sequencedPercentageP-valueapUC18-2bp-repeatNon-silencing control siRNA121963Lig1 siRNA1522680.735Lig3 siRNA623260.016Lig4 siRNA1216750.452pUC18-3bp-repeatNon-silencing control siRNA132162Lig1 siRNA919470.356Lig3 siRNA722320.048Lig4 siRNA1120550.654aComparisons of the fraction of end joined products mediated by 2- or 3-bp repeats at the ends of substrates in HTD114 nuclear extracts with siRNA treatments against different ligases to the control siRNA were done with contingency tables. Significant levels were determined with chi-squared test.
###end p 53
###begin p 54
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
Sequences of junctions of end-joined productsa
###end p 54
###begin p 55
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aNuclear extract was prepared from HTD114 cells treated with different siRNAs.
###end p 55
###begin p 56
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 146 165 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#9662;</sup>
bThe deleted sequences are indicated by capital letters and the flanking sequences are in lower case. Direct repeats are underlined. The symbol, 'black triangle down', denotes the ends of two joined DNA molecules. Italic letters represent the inserted sequence.
###end p 56
###begin p 57
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cPR, perfect rejoining.
###end p 57
###begin p 58
Fractions of end-joined products mediated by 2-bp (AG) or 3-bp (CAG) repeats at the ends of substrates
###end p 58
###begin p 59
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aComparisons of the fraction of end joined products mediated by 2- or 3-bp repeats at the ends of substrates in HTD114 nuclear extracts with siRNA treatments against different ligases to the control siRNA were done with contingency tables. Significant levels were determined with chi-squared test.
###end p 59
###begin p 60
###xml 43 51 43 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 261 269 261 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 716 724 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 848 856 848 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 902 911 902 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 916 917 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
By multiplying the end-joining efficiency (Figure 8A and B) with the fraction of end-joined products mediated by 2- or 3-bp microhomology (Table 2), we were able to determine the effect of siRNA against DNA ligases I, III or IV on 2- and 3-bp MHEJ. As shown in Figure 8C, while siRNA 121249, which depletes ligase I, decreased the activity of 2-bp MHEJ to 88% of the control, it reduced the activity of 3-bp MHEJ to 54% of the control, suggesting that DNA ligase I plays a more important role in 3-bp MHEJ than in 2-bp MHEJ. The siRNA 121668, which reduces ligase III, had a greater inhibitory effect on 2- and 3-bp MHEJ than siRNA 121249. The activities of both 2- and 3-bp MHEJ were only about 20% of the control (Figure 8C and D). Interestingly, siRNA 121372, which reduces ligase IV, increased the activity of 2-bp MHEJ to 133% of the control (Figure 8C), consistent with its effect on 10-bp MHEJ (Figures 6 and 7).
###end p 60
###begin title 61
DISCUSSION
###end title 61
###begin p 62
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 574 583 574 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figures 2</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
###xml 810 818 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 936 945 936 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3</xref>
###xml 950 951 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 1023 1034 1023 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6 F7 F8">Figures 6&#8211;8</xref>
###xml 1116 1124 1116 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
###xml 639 646 <span type="species:ncbi:9606">patient</span>
###xml 978 983 <span type="species:ncbi:9606">human</span>
###xml 1175 1180 <span type="species:ncbi:9606">human</span>
The presence of multiple DNA ligases in eukaryotic cells suggests that these enzymes may each have specific functions. This notion is supported by findings showing that mammalian cell lines deficient in either DNA ligase I, III or IV exhibit different phenotypes (32). We showed here that human DNA ligases I and III contribute to microhomology-mediated end joining (MHEJ). The supporting evidence includes: first, siRNA-mediated down-regulation of DNA ligase I or III in human HTD114 cells leads to impaired joining of DNA ends mediated by a 10-, 2- or 3-bp microhomology (Figures 2, 4 and 8); second, GM16096, a cell line derived from a patient with immunodeficiency, increased sensitivity to DNA-damaging agents, and delayed development due to loss of DNA ligase I function, showed decreased level of MHEJ (Figure 3); third, treatment of HTD114 nuclear extracts with antiserum against DNA ligase I or III significantly reduced MHEJ (Figures 3 and 5). We have also shown that human DNA ligase IV is not required in MHEJ (Figures 6-8). In addition, reduction of ligase IV significantly decreased Ku-dependent NHEJ (Figure 6). Taken together, these findings demonstrate that human DNA ligases I, III and IV each play a different role in MHEJ and Ku-dependent NHEJ, the two end-joining pathways for DNA DSBs.
###end p 62
###begin p 63
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1239 1244 1226 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32 B33 B34">32&#8211;34</xref>
###xml 1459 1460 1446 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1461 1463 1448 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
DNA ligase I functions in DNA replication to join Okazaki fragments during lagging-strand DNA synthesis and in DNA BER to seal single-strand nicks (30). Our data indicate that DNA ligase I is also involved in end joining of DNA DSBs, especially in MHEJ. Although ligase I interacts with several different proteins in DNA replication and BER (17,32), it remains unclear whether or not it acts alone in MHEJ. It has been shown that the amino terminus of the DNA ligase I protein has a proliferating cell nuclear antigen (PCNA)-binding motif that is required for the loading of the DNA ligase I protein to replication foci within the nuclei of S-phase cells (20). Moreover, the PCNA-binding motif is required for the efficient joining of Okazaki fragments and completion of long patch BER in cell extract assays (21). Accumulating evidence suggests that in addition to DNA ligase I, PCNA interacts with DNA polymerases delta epsilon and beta replication factor C (RFC), and a DNA structure-specific endonuclease (FEN-1), and coordinates their activities by forming complexes that are involved in several DNA metabolic pathways, including the processing of Okazaki fragments, and the repair of DNA base damage and single-strand breaks (SSBs) (32-34). Therefore, it is reasonable to speculate that PCNA coordinates the involvement of DNA ligase I and other factors, such as FEN-1, in MHEJ. Indeed, it has been reported that FEN-1 is required for the MHEJ pathway (9,35). It is possible that FEN-1 is responsible for the removal of single-stranded flaps formed from broken DNA ends during MHEJ, and then ligase I seals the remaining nick. All these processes are probably mediated by the protein-protein interaction of FEN-1 and ligase I with PCNA.
###end p 63
###begin p 64
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 264 269 264 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37">35&#8211;37</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 973 978 973 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Besides its critical role in the repair of damaged bases and SSBs (32), evidence from several studies suggests that DNA ligase III is also involved in DSB repair through an alternative route of DSB repair that complement the DNA-PK/XRCC4/ligase IV-dependent NHEJ (35-37). In line with these findings, we have shown that DNA ligase III is required for MHEJ. While ligase III exists in a tight complex with XRCC1 (23) in BER to repair DNA base damage and DNA SSBs (38,39), it was also reported that the Ku-independent end-joining, which may be mediated by microhomology sequences, required the synapsis activity of poly(ADP-ribose) polymerase 1 (PARP-1) and the ligation activity of the XRCC1-DNA ligase III complex (36), implying that ligase III may also work together with other factors in MHEJ. However, amongst DNA ligases, ligase III is unique in having a zinc-finger motif at the N-terminus (40), enabling its recruitment to DNA strand breaks (41). Furthermore, Taylor et al. (42) reported that the zinc-finger motif confers upon ligase III the ability to bind DNA duplexes and stimulates intermolecular end joining between DNA duplexes. Therefore, the possibility that ligase III functions alone in DNA end joining can not be excluded.
###end p 64
###begin p 65
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 251 253 251 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CS</sub>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 410 418 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 889 890 889 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1553 1558 1553 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1561 1563 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1934 1936 1928 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 1802 1807 <span type="species:ncbi:4932">yeast</span>
Like DNA ligase III that forms a complex with XRCC1, DNA ligase IV is tightly associated with XRCC4, upon which it depends for stability and activity (24,25,43). Strikingly, ligase IV-XRCC4 complex functions in coupling with Ku heterodimers and DNA PKCS in NHEJ, but not in other DNA repair pathways (44). In line with this notion, we here demonstrated that DNA ligase IV facilitated Ku-dependent end joining (Figure 6), but was not required for MHEJ (Figures 6 and 7). Furthermore, when ligase IV was absent, the activity of MHEJ in the nuclear extract was increased, suggesting that DNA ligase IV may negatively regulate the MHEJ pathway. It is not clear how ligase IV inhibits MHEJ. One possibility is that the Ku-ligase IV-XRCC4-dependent NHEJ pathway, which is initiated by binding of Ku proteins to DNA ends, may compete with the MHEJ pathway for binding to and processing DNA ends (9). Once the DNA ends are ligated by DNA ligase IV/XRCC4 complex, Ku proteins presumably become dissociated from DNA, and bind to other DNA ends to start another round of NHEJ reaction. Lack of DNA ligase IV would lead to an incomplete NHEJ reaction in which Ku proteins cannot be released from DNA ends. Due to lack of competition caused by a shortage of recycled Ku proteins, DNA ends would have a greater chance to be exposed to nuclease attack and to be joined by the alternative MHEJ pathway. In addition, there is growing evidence showing that DNA ligase IV may coordinate DNA processing activities that are critical for both NHEJ and MHEJ. For instance, Ma et al. (45) showed that there are conserved physical and functional interactions between DNA polymerase (pol) X family members (pol mu and pol lambda) and DNA ligase IV that coordinate gap-filling DNA synthesis and DNA ligation in NHEJ. Notably, in yeast, DNA ligase IV physically and functionally interacts with Rad27 (FEN-1 in mammalian cells) to process and join DNA molecules (46). Therefore, while ligase IV, by interacting with other DNA processing proteins, may facilitate the Ku-dependent NHEJ pathway, it may inhibit MHEJ as a consequence of the competition for components common to both pathways.
###end p 65
###begin p 66
###xml 637 644 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 779 784 779 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37">35&#8211;37</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Overall, our work showed that human DNA ligase I and ligase III, which are involved in long patch BER and short patch BER, respectively, to repair DNA base damage and SSBs, are also critical for the repair of DSBs by MHEJ. It should also be noted that the requirement of ligase I and III seems to vary depending on the length of microhomology sequences. While a reduction in ligase III affects MHEJ using both short and long microhomology, a reduction in ligase I had only slightly affected MHEJ using 2-bp repeats, though it greatly decreased the MHEJ using 10-bp repeats. Since the 2- and 3-bp substrates are much more likely to occur in vivo, ligase III is probably the primary ligase contributing to MHEJ. This notion is in accordance with previously published observations (35-37). Furthermore, our observations also suggest that DNA ligase I and ligase III may function in MHEJ through two independent pathways. In keeping up with this notion, protein partners of DNA ligases I and III, which are required for their stability, DNA-binding recruitment and catalytic activity, have never been shown to overlap. Although little is known about whether or not other factors may be involved in MHEJ, further studies of factors involved in the repair of DNA base damage and SSBs by using our end-joining assay may shed more light on the mechanisms of DNA DSB repair.
###end p 66
###begin title 67
ACKNOWLEDGEMENTS
###end title 67
###begin p 68
This work was supported by grants from the National Institutes of Health (ES011633 and P30ES05022), the National Aeronautics and Space Administration (NNG05GN24G), and New Jersey Stem Cell Research grants from New Jersey Commission on Science and Technology (06-2042-014-85 and 07-2042-014-90). Funding to pay the Open Access publication charges for this article was provided by the New Jersey Stem Cell Research grant (07-2042-014-90).
###end p 68
###begin p 69
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin article-title 71
Defying death after DNA damage
###end article-title 71
###begin article-title 72
Sensing and repairing DNA double-strand breaks
###end article-title 72
###begin article-title 73
###xml 28 33 <span type="species:ncbi:9606">human</span>
Mechanism and regulation of human non-homologous DNA end-joining
###end article-title 73
###begin article-title 74
Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity
###end article-title 74
###begin article-title 75
DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus
###end article-title 75
###begin article-title 76
DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining
###end article-title 76
###begin article-title 77
Double-strand break repair in Ku86- and XRCC4-deficient cells
###end article-title 77
###begin article-title 78
Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA
###end article-title 78
###begin article-title 79
Modulation of DNA end joining by nuclear proteins
###end article-title 79
###begin article-title 80
Backup pathways of NHEJ are suppressed by DNA-PK
###end article-title 80
###begin article-title 81
###xml 58 63 <span type="species:ncbi:9606">human</span>
Impact of DNA ligase IV on the fidelity of end joining in human cells
###end article-title 81
###begin article-title 82
Biochemical evidence for Ku-independent backup pathways of NHEJ
###end article-title 82
###begin article-title 83
Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells
###end article-title 83
###begin article-title 84
###xml 87 92 <span type="species:ncbi:9606">human</span>
Formation of large deletions by illegitimate recombination in the HPRT gene of primary human fibroblasts
###end article-title 84
###begin article-title 85
DNA sequence determination of gamma-radiation-induced mutations of the hamster aprt locus
###end article-title 85
###begin article-title 86
Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations
###end article-title 86
###begin article-title 87
DNA ligases in the repair and replication of DNA
###end article-title 87
###begin article-title 88
ATP-dependent DNA ligases
###end article-title 88
###begin article-title 89
An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining
###end article-title 89
###begin article-title 90
DNA ligase I is recruited to sites of DNA replication by an interaction with proliferating cell nuclear antigen: identification of a common targeting mechanism for the assembly of replication factories
###end article-title 90
###begin article-title 91
Interaction between PCNA and DNA ligase I is critical for joining of Okazaki fragments and long-patch base-excision repair
###end article-title 91
###begin article-title 92
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
An alternative splicing event which occurs in mouse pachytene spermatocytes generates a form of DNA ligase III with distinct biochemical properties that may function in meiotic recombination
###end article-title 92
###begin article-title 93
An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III
###end article-title 93
###begin article-title 94
Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4
###end article-title 94
###begin article-title 95
Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells
###end article-title 95
###begin article-title 96
DNA double-strand break repair
###end article-title 96
###begin article-title 97
###xml 50 55 <span type="species:ncbi:9606">human</span>
Expression profiling of crystal-induced injury in human kidney epithelial cells
###end article-title 97
###begin article-title 98
Repair of deletions and double-strand gaps by homologous recombination in a mammalian in vitro system
###end article-title 98
###begin article-title 99
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
###end article-title 99
###begin article-title 100
Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents
###end article-title 100
###begin article-title 101
Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity
###end article-title 101
###begin article-title 102
DNA ligases: structure, reaction mechanism, and function
###end article-title 102
###begin article-title 103
XRCC1 and DNA strand break repair
###end article-title 103
###begin article-title 104
Proliferating cell nuclear antigen (PCNA): a dancer with many partners
###end article-title 104
###begin article-title 105
Rejoining of DNA double-strand breaks in vitro by single-strand annealing
###end article-title 105
###begin article-title 106
Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
###end article-title 106
###begin article-title 107
DNA ligase III as a candidate component of backup pathways of nonhomologous end joining
###end article-title 107
###begin article-title 108
A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange
###end article-title 108
###begin article-title 109
###xml 25 30 <span type="species:ncbi:9606">human</span>
Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange
###end article-title 109
###begin article-title 110
###xml 36 41 <span type="species:ncbi:9606">human</span>
Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination
###end article-title 110
###begin article-title 111
DNA ligase III is recruited to DNA strand breaks by a zinc finger motif homologous to that of poly(ADP-ribose) polymerase. Identification of two functionally distinct DNA binding regions within DNA ligase III
###end article-title 111
###begin article-title 112
The DNA ligase III zinc finger stimulates binding to DNA secondary structure and promotes end joining
###end article-title 112
###begin article-title 113
Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV
###end article-title 113
###begin article-title 114
XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining
###end article-title 114
###begin article-title 115
A biochemically defined system for mammalian nonhomologous DNA end joining
###end article-title 115
###begin article-title 116
Processing and joining of DNA ends coordinated by interactions among Dnl4/Lif1, Pol4, and FEN-1
###end article-title 116

